These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26743549)

  • 1. [Standard antiviral therapies against HCV infection].
    Sakamoto N
    Nihon Shokakibyo Gakkai Zasshi; 2016; 113(1):20-4. PubMed ID: 26743549
    [No Abstract]   [Full Text] [Related]  

  • 2. Emerging therapies for hepatitis C virus (HCV) infection: the importance of HCV genotype.
    McCaughan GW; Strasser SI
    Aust N Z J Med; 2000 Dec; 30(6):644-6. PubMed ID: 11198570
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular biology of hepatitis C infection.
    Drazan KE
    Liver Transpl; 2000 Jul; 6(4):396-406. PubMed ID: 10915159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [How to treat non-responders to antiviral bitherapy for hepatitis C?].
    Guyader D
    Gastroenterol Clin Biol; 2007 Mar; 31(3):317-24. PubMed ID: 17396096
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet Needs.
    Naggie S; Muir AJ
    Annu Rev Med; 2017 Jan; 68():345-358. PubMed ID: 27686017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment choice of the antiviral agent for the hepatitis C].
    Karino Y
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():269-73. PubMed ID: 26845943
    [No Abstract]   [Full Text] [Related]  

  • 7. New Drug Treats All Genotypes of Chronic HCV.
    Aschenbrenner DS
    Am J Nurs; 2016 Oct; 116(10):27. PubMed ID: 27684768
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of a patient with genotype 7 hepatitis C virus infection with sofosbuvir and velpatasvir.
    Schreiber J; McNally J; Chodavarapu K; Svarovskaia E; Moreno C
    Hepatology; 2016 Sep; 64(3):983-5. PubMed ID: 27177605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in hepatitis C: what is coming in the next 5 years?
    Locarnini SA; Bartholomeusz A
    J Gastroenterol Hepatol; 2002 Apr; 17(4):442-7. PubMed ID: 11982725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel hepatitis C drugs in current trials.
    Kronenberger B; Welsch C; Forestier N; Zeuzem S
    Clin Liver Dis; 2008 Aug; 12(3):529-55, viii. PubMed ID: 18625427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NIH panel recommends combination HCV treatment.
    Traynor K
    Am J Health Syst Pharm; 2002 Jul; 59(14):1320. PubMed ID: 12132554
    [No Abstract]   [Full Text] [Related]  

  • 12. Searching for synergy: Identifying optimal antiviral combination therapy using Hepatitis C virus (HCV) agents in a replicon system.
    Pomeroy JJ; Drusano GL; Rodriquez JL; Brown AN
    Antiviral Res; 2017 Oct; 146():149-152. PubMed ID: 28882564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapies for hepatitis C virus based on lessons from virology.
    Glenn JS
    Clin Gastroenterol Hepatol; 2005 Oct; 3(10 Suppl 2):S86-8. PubMed ID: 16234068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy.
    Serpaggi J; Chaix ML; Batisse D; Dupont C; Vallet-Pichard A; Fontaine H; Viard JP; Piketty C; Rouveix E; Rouzioux C; Weiss L; Pol S
    AIDS; 2006 Jan; 20(2):233-40. PubMed ID: 16511416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular basis for responsiveness to anti-viral therapy in hepatitis C.
    Polyak SJ; Gerotto M
    Forum (Genova); 2000; 10(1):46-58. PubMed ID: 10717257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future therapies for hepatitis C virus infection.
    Ozaras R; Yemisen M; Balkan İİ
    N Engl J Med; 2013 Aug; 369(7):679. PubMed ID: 23944319
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of novel anti-HCV therapies: HCV protease, helicase, and polymerase as therapeutic targets.
    Hong Z; Standring DN; Baroudy B; Lau JY
    Acta Gastroenterol Belg; 2000; 63(2):210-2. PubMed ID: 10925468
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C virus viral assays in the direct-acting antiviral era.
    Vierling JM
    Clin Liver Dis; 2013 Feb; 17(1):27-45. PubMed ID: 23177281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Final stage in antivirus therapy for HCV patients with chronic liver disease].
    Arase Y
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():36-9. PubMed ID: 26845903
    [No Abstract]   [Full Text] [Related]  

  • 20. Practical insights into enhanced management of patients with HCV infection with direct antiviral agents.
    Colombo M; Zeuzem S
    Dig Liver Dis; 2013 Sep; 45 Suppl 5():S313. PubMed ID: 24091108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.